Today, we’re excited to announce three new companies we backed that reflect a thesis we believe is becoming increasingly important: the next generation of breakout companies will not just improve existing systems, they will rebuild foundational infrastructure across industries that millions of people rely on every day.
At LvlUp Ventures, we spend a significant amount of time looking for founders operating at the intersection of technical depth, execution speed, and real market demand. The companies that stand out are rarely the loudest. They are the ones already demonstrating traction before most people are paying attention.
That is exactly what we saw in DatumIQ, SPACELING®, and Immumem Therapeutics.
Modern enterprises generate enormous amounts of data, yet the majority of it remains inaccessible or underutilized. Internal dashboards are fragmented, engineering bottlenecks slow decision-making, and extracting useful insights often requires expensive technical teams.
DatumIQ is solving this problem with an AI-powered analytics platform designed to transform raw data into actionable dashboards in under 20 minutes.
The opportunity is massive. As organizations continue adopting AI-driven workflows, the ability to quickly operationalize data becomes increasingly critical. DatumIQ is positioning itself as the infrastructure layer that enables businesses to move from data collection to decision-making without the traditional complexity.
The company already has strong early traction, including:
Most importantly, the founding team understands both the technical and commercial sides of the problem, giving them a unique advantage in a rapidly expanding market.
Social media platforms have become increasingly driven by outrage, misinformation, and algorithmic manipulation. SPACELING® is taking a fundamentally different approach.
The company is building a next-generation social platform centered around authenticity, anti-toxicity systems, and user-aligned monetization. Their vision is not simply another social app, but a new infrastructure model for digital communities.
What impressed us most is the level of traction achieved before public launch:
In an industry where user trust continues to decline, SPACELING® is approaching social infrastructure from a completely different angle. We believe that creates an opportunity far larger than most people realize.
Biotech remains one of the most difficult sectors to build in, but also one of the most impactful.
Immumem Therapeutics is developing next-generation memory cell therapies designed to address one of oncology’s biggest challenges: relapse in solid tumors.
Their approach combines allogeneic iPSC-derived memory T and NK cells with predictive AI infrastructure, creating therapies designed not only to attack tumors, but to continuously monitor and prevent recurrence over time.
Several early signals stood out:
The company is operating in one of the most technically demanding areas of biotech, but the combination of scientific rigor and operational execution gives us strong conviction in the direction they are building toward.
Although these companies operate in completely different industries, they share the same underlying characteristics:
At LvlUp Ventures, those are the signals we pay attention to.
We’re proud to back DatumIQ, SPACELING®, and Immumem Therapeutics as they continue scaling toward their next milestones, and we’re excited to support them in the journey ahead.
Subscribe to our newsletter to stay up to date with the latest news.
